 |
PLLA
Bouliga
3913900090
Bouliga
wrinkles filler
1ml
| Size: | |
|---|---|
Main Ingredients: Poly-L-lactic acid (PLLA), Hyaluronic Acid
Mechanism of Action: Upon injection, it stimulates the body’s endogenous fibroblasts to gradually boost collagen synthesis, thereby achieving skin plumping and firming effects. PLLA exhibits excellent biocompatibility and biodegradability; it is ultimately degraded in the body into lactic acid and carbon dioxide, which are then excreted.
Indications/Uses: It is Indicated for deep dermal and subcutaneous injection to correct midfacial volume deficiency and midfacial contour abnormalities. Specific applications include facial contouring (e.g., filling temporal and cheek hollows), wrinkle reduction (e.g., improving nasolabial folds), and mandibular contouring. Additionally, PLLA is widely used in orthopedic fixation materials, medical sutures, tissue engineering scaffolds, and drug delivery systems.
Contraindicated Population
1. Individuals in the active stage of skin infection, active stage of skin herpes, or active stage of allergy
2. Pregnant women, lactating women, and minors
3. Patients with autoimmune diseases
4. Individuals with a scar-forming constitution / Keloid-prone individuals
5. Individuals receiving long-term anticoagulant therapy or taking similar dietary supplements (use with caution)
Furthermore, to ensure safety and efficacy, consumers are advised to use medical aesthetic products under the guidance of licensed physicians or qualified medical aesthetic professionals, and to purchase and use such products in a scientific and appropriate manner.
Main Ingredients: Poly-L-lactic acid (PLLA), Hyaluronic Acid
Mechanism of Action: Upon injection, it stimulates the body’s endogenous fibroblasts to gradually boost collagen synthesis, thereby achieving skin plumping and firming effects. PLLA exhibits excellent biocompatibility and biodegradability; it is ultimately degraded in the body into lactic acid and carbon dioxide, which are then excreted.
Indications/Uses: It is Indicated for deep dermal and subcutaneous injection to correct midfacial volume deficiency and midfacial contour abnormalities. Specific applications include facial contouring (e.g., filling temporal and cheek hollows), wrinkle reduction (e.g., improving nasolabial folds), and mandibular contouring. Additionally, PLLA is widely used in orthopedic fixation materials, medical sutures, tissue engineering scaffolds, and drug delivery systems.
Contraindicated Population
1. Individuals in the active stage of skin infection, active stage of skin herpes, or active stage of allergy
2. Pregnant women, lactating women, and minors
3. Patients with autoimmune diseases
4. Individuals with a scar-forming constitution / Keloid-prone individuals
5. Individuals receiving long-term anticoagulant therapy or taking similar dietary supplements (use with caution)
Furthermore, to ensure safety and efficacy, consumers are advised to use medical aesthetic products under the guidance of licensed physicians or qualified medical aesthetic professionals, and to purchase and use such products in a scientific and appropriate manner.
